Hundreds of peer-reviewed studies on marijuana and its components have been published in the first seven months of 2025, marking a surge in new research. In this article, we break down the 200 most important of these studies.
These studies cover a wide spectrum of conditions, from autoimmune disorders and mental health issues to gastrointestinal diseases and metabolic dysfunction. In addition, researchers are increasingly turning their attention to cannabinoids beyond THC and CBD, such as CBG, THCV, and CBC. Many studies also focus on novel delivery systems—like oral dissolvable films, skin patches, and advanced emulsions—while investigating how marijuana may affect pain regulation, sleep quality, immune response, and emotional health.
What follows is a detailed roundup of more than 200 marijuana-related studies released so far this year.
Hellbound and Down 